好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Imperfect Pitch: a Cellist’s Struggle with Tics, PRRT2, and Carbamazepine
Movement Disorders
P12 - Poster Session 12 (5:30 PM-6:30 PM)
5-016
NA

Paroxysmal kinesigenic dyskinesia (PKD) is characterized by sudden, brief dystonic or choreiform movements triggered by abrupt movement. Pathogenic heterozygous mutations in the PRRT2 gene are responsible for approximately 50% of cases. PRRT2 mutations have variable phenotypes: benign familial infantile epilepsy, infantile convulsions with paroxysmal choreoathetosis, episodic ataxia, and hemiplegic migraine. PRRT2 mutations can have overlapping features with PNKD (non kinesigenic).

Case Report

A 19-year-old Asian/Caucasian male cello player with history of motor tic disorder and ADHD presented to our clinic after he experienced sudden-onset, complex choreiform, ballistic movements during an orchestra performance in front of a live audience (see video). His "tics" began at age 7 with brief facial movements, which were partially suppressible and preceded by an urge. A few years later, he developed complex, generalized choreiform movements, lasting up to 30 seconds and occurring up to five times per day, which were non-suppressible, preceded by a sense of tension in his legs, and increased in frequency during stressful times. Genetic testing detected a pathogenic heterozygous mutation in the PRRT2 gene at Exon 2, c.649dup (p.Arg217Profs*8). Initiation of carbamazepine resulted in resolution of symptoms but also alteration of pitch perception (decreased by a semitone), a previously reported idiosyncratic side effect of carbamazepine, normalizing within days of medication discontinuation. He was then treated with lacosamide 100mg daily, completely ameliorating symptoms without adverse effects.

Tics have rarely been reported as co-occurring with PKD, but in one observational study, tics were present in 79% of patients with PKD, making this an under-recognized phenomenon. Additionally, this case highlights a rare side effect of carbamazepine, alteration of pitch, which is likely only appreciated by patients with absolute pitch. Finally, it raises the possibility of an association between PKD and stuttering since there is a strong family history of stuttering in this patient.

Authors/Disclosures
Matthew Feldman, MD
PRESENTER
Dr. Feldman has nothing to disclose.
Sarah Marmol, MD Dr. Marmol has nothing to disclose.
Jennifer Hislop, MD Dr. Hislop has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Veterans Affairs.
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Ihtsham Haq, MD, FAAN (University of Miami Miller School of Medicine) The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Jason H. Margolesky, MD, FAAN (University of Miami School of Medicine) Dr. Margolesky has nothing to disclose.